News
FDA approves new drugs
·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with…
FDA approves drug for rare metabolic disorder
On Sept. 4, the U.S. Food and Drug Administration (FDA) approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria,…
FDA approves drug for sexual desires disorders in women
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.…
FDA approves new cholesterol-lowing drug
On July 24, the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) injection, the first cholesterol-lowering treatment approved in a new class of…
FDA approves new device for treating obesity
On July 28, the U.S. Food and Drug Administration (FDA) approved the ReShape Integrated Dual Balloon System to treat obesity in adults. Read more.
FDA authorizes prosthesis for above-the-knee amputations
On July 16, the U.S. Food and Drug Administration (FDA) authorized use of the first prosthesis marketed in the U.S. for adults who have…
FDA approves new drug for schizophrenia and new drug for lung cancer
On July 13, the U.S. Food and Drug Administration (FDA) approved Rexulti (brexpiprazole) to treat adults with schizophrenia and as an add-on treatment to…
FDA approves new drugs
·On Sept. 22, the U.S. Food and Drug Administration (FDA) approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for…
FDA approves drug for rare metabolic disorder
On Sept. 4, the U.S. Food and Drug Administration (FDA) approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary…
FDA approves drug for sexual desires disorders in women
On Aug. 18, the U.S. Food and Drug Administration (FDA) approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder in…
FDA approves new cholesterol-lowing drug
On July 24, the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) injection, the first cholesterol-lowering treatment approved in a new…
FDA approves new device for treating obesity
On July 28, the U.S. Food and Drug Administration (FDA) approved the ReShape Integrated Dual Balloon System to treat obesity in adults.…
FDA authorizes prosthesis for above-the-knee amputations
On July 16, the U.S. Food and Drug Administration (FDA) authorized use of the first prosthesis marketed in the U.S. for adults…
FDA approves new drug for schizophrenia and new drug for lung cancer
On July 13, the U.S. Food and Drug Administration (FDA) approved Rexulti (brexpiprazole) to treat adults with schizophrenia and as an add-on…
Test Your Knowledge
skin cancer tyk
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.